(2024)
Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
FRONTIERS IN ONCOLOGY.
14,
1
(2023)
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer.
Radiation Oncology Journal.
41,
4
(2023)
Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma?.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
117,
4
(2023)
Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis.
THORACIC CANCER.
14,
36
(2023)
The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer.
CANCER RESEARCH AND TREATMENT.
55,
3
(2023)
Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.
SUPPORTIVE CARE IN CANCER.
31,
6
(2023)
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
MODERN PATHOLOGY.
36,
7
(2023)
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
115,
2
(2023)
Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors.
Radiation Oncology Journal.
41,
1
(2023)
Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells.
FRONTIERS IN ONCOLOGY.
13,
1
(2022)
Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.
23,
24
(2022)
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
RADIOTHERAPY AND ONCOLOGY.
176,
(2022)
Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.
CANCERS.
14,
17
(2022)
Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.
CANCERS.
14,
15
(2022)
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer.
EUROPEAN JOURNAL OF CANCER.
169,
-
(2022)
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.
113,
2
(2022)
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy.
Radiation Oncology Journal.
40,
1
(2022)
Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis.
CANCERS.
14,
6
(2022)
Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer.
LIFE-BASEL.
12,
2
(2022)
Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx.
CANCER RESEARCH AND TREATMENT.
54,
1
학술회의논문
(2023)
The Role of Neoadjuvant CCRT for N2 NSCLC.
Korean Association for Lung Cancer International Conference.
대한민국
(2023)
The Role of Chemoradiation as Definitive and Neoadjuvant Setting.
Best of WCLC 2023.
대한민국
(2023)
Implementation of CES-IMRT in locally advanced NSCLC patients and the outcomes of esophageal toxicity and intra-thoracic failure pattern..
Radiation Oncology Journal.
대한민국
(2023)
Life Expectancy Estimation in Patients Receiving Palliative Radiotherapy for Stage IV Cancer.
Radiation Oncology Journal.
대한민국
(2023)
Prognostic impact of sarcopenia in elderly patients with locally advanced esophageal cancer receiving neoadjuvant chemoradiation therapy.
Radiation Oncology Journal.
대한민국
(2023)
Role of radiation alone versus concurrent chemoradiotherapy in surgically ineligible patients with tracheobronchial squamous cell carcinoma.
Radiation Oncology Journal.
대한민국
(2023)
The implication of failure patterns after neoadjuvant chemoradiotherapy with small involved-field in esophageal squamous cell carcinoma.
Radiation Oncology Journal.
대한민국
(2023)
The prediction of pathologic complete response using liquid biopsy based on cfDNA methylation in esophageal cancer patients receiving neoadjuvant chemoradiotherapy.
Radiation Oncology Journal.
대한민국
(2023)
Monitoring and Prediction for Clinical Outcomes after Radiotherapy.
49th Annual Meeting of Korean Cancer Association and the 9th International Cancer Conference.
대한민국
(2023)
Radiotherapy for Locally Recurrent or Metastatic Thyroid Cancer.
2023년 대한두경부종양학회 춘계학술대회.
대한민국
(2023)
Combination with proton.
2023년 표적치료연구회 춘계학술대회.
대한민국
(2020)
Optimal Application of Proton Therapy for Lung Cancer.
2020 KALC International Conference Virtual.
대한민국
(2020)
Clinical outcomes of pencil beam scanning proton therapy in locally advanced non-small cell lung cancer: propensity score analysis.
대한방사선종양학회 추계학회.
대한민국
(2020)
Early Clinical outcomes of helical tomotherapy/intensity modulated proton therapy combination in oropharynx cancer.
대한방사선종양학회 추계학회.
대한민국
(2020)
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy.
대한방사선종양학회 추계학회.
대한민국
(2020)
Liquid biopsy before and afrer RT as predictors.
대한방사선종양학회 추계학회.
대한민국
(2020)
Machine Learning-Based Model to Predict Excessive Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
대한방사선종양학회 추계학회.
대한민국
(2020)
Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer.
대한방사선종양학회 추계학회.
대한민국
(2020)
Role of radiotherapy in SCLC.
The 42nd Consensus Conference두경부식도암&폐암.
대한민국
